Charles Schwab Investment Management Inc Coherus Bio Sciences, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 981,372 shares of CHRS stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
981,372
Previous 950,676 3.23%
Holding current value
$1.76 Million
Previous $770,000 7.01%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$0.72 - $1.12 $22,101 - $34,379
30,696 Added 3.23%
981,372 $716,000
Q1 2025

Sep 15, 2025
SELL
$0.81 - $1.66 $24,863 - $50,955
-30,696 Reduced 3.13%
950,676 $770,000
Q1 2025

May 09, 2025
SELL
$0.81 - $1.66 $21,206 - $43,460
-26,181 Reduced 2.68%
950,676 $770,000
Q4 2024

Feb 06, 2025
BUY
$0.67 - $1.71 $8,395 - $21,426
12,530 Added 1.3%
976,857 $1.35 Million
Q3 2024

Nov 12, 2024
BUY
$0.99 - $1.8 $115,054 - $209,190
116,217 Added 13.7%
964,327 $1 Million
Q2 2024

Aug 12, 2024
BUY
$1.58 - $2.51 $251,194 - $399,049
158,984 Added 23.07%
848,110 $1.47 Million
Q1 2024

May 08, 2024
SELL
$2.02 - $3.14 $158,713 - $246,712
-78,571 Reduced 10.23%
689,126 $1.65 Million
Q4 2023

Feb 06, 2024
BUY
$1.59 - $3.85 $70,476 - $170,651
44,325 Added 6.13%
767,697 $2.56 Million
Q3 2023

Nov 08, 2023
BUY
$3.74 - $5.45 $723,499 - $1.05 Million
193,449 Added 36.51%
723,372 $2.71 Million
Q2 2023

Aug 09, 2023
BUY
$3.79 - $8.3 $93,540 - $204,852
24,681 Added 4.88%
529,923 $2.26 Million
Q1 2023

May 11, 2023
SELL
$5.89 - $10.52 $9,111 - $16,274
-1,547 Reduced 0.31%
505,242 $3.46 Million
Q4 2022

Feb 13, 2023
BUY
$5.69 - $10.07 $82,197 - $145,471
14,446 Added 2.93%
506,789 $4.01 Million
Q3 2022

Nov 14, 2022
BUY
$7.17 - $13.87 $117,200 - $226,719
16,346 Added 3.43%
492,343 $4.73 Million
Q2 2022

Aug 15, 2022
BUY
$5.86 - $13.23 $49,763 - $112,349
8,492 Added 1.82%
475,997 $3.45 Million
Q1 2022

May 13, 2022
SELL
$10.92 - $16.41 $84,433 - $126,882
-7,732 Reduced 1.63%
467,505 $6.04 Million
Q4 2021

Feb 11, 2022
BUY
$15.81 - $18.99 $124,566 - $149,622
7,879 Added 1.69%
475,237 $7.59 Million
Q3 2021

Nov 16, 2021
SELL
$12.68 - $17.79 $105,497 - $148,012
-8,320 Reduced 1.75%
467,358 $7.51 Million
Q2 2021

Aug 16, 2021
BUY
$12.95 - $15.41 $113,118 - $134,606
8,735 Added 1.87%
475,678 $6.58 Million
Q1 2021

May 17, 2021
SELL
$14.42 - $21.39 $580,116 - $860,519
-40,230 Reduced 7.93%
466,943 $6.82 Million
Q4 2020

Feb 16, 2021
SELL
$16.56 - $18.94 $125,839 - $143,925
-7,599 Reduced 1.48%
507,173 $8.82 Million
Q3 2020

Nov 13, 2020
SELL
$17.41 - $19.89 $1.81 Million - $2.06 Million
-103,718 Reduced 16.77%
514,772 $9.44 Million
Q2 2020

Aug 14, 2020
SELL
$14.43 - $19.16 $102,640 - $136,285
-7,113 Reduced 1.14%
618,490 $11 Million
Q1 2020

May 15, 2020
SELL
$11.67 - $22.53 $459,681 - $887,456
-39,390 Reduced 5.92%
625,603 $10.1 Million
Q4 2019

Feb 07, 2020
BUY
$16.33 - $21.37 $4.66 Million - $6.09 Million
285,108 Added 75.05%
664,993 $12 Million
Q3 2019

Nov 08, 2019
BUY
$16.3 - $23.37 $488,217 - $699,978
29,952 Added 8.56%
379,885 $7.7 Million
Q2 2019

Aug 09, 2019
BUY
$13.1 - $22.1 $400,650 - $675,906
30,584 Added 9.58%
349,933 $7.73 Million
Q1 2019

May 14, 2019
BUY
$8.38 - $15.5 $138,345 - $255,889
16,509 Added 5.45%
319,349 $4.36 Million
Q4 2018

Feb 14, 2019
BUY
$8.65 - $16.28 $1,980 - $3,728
229 Added 0.08%
302,840 $2.74 Million
Q3 2018

Nov 13, 2018
BUY
$14.45 - $20.25 $670,436 - $939,539
46,397 Added 18.11%
302,611 $4.99 Million
Q2 2018

Aug 08, 2018
BUY
$10.25 - $17.45 $462,726 - $787,762
45,144 Added 21.39%
256,214 $3.59 Million
Q1 2018

May 07, 2018
BUY
$9.1 - $13.7 $194,494 - $292,810
21,373 Added 11.27%
211,070 $2.33 Million
Q4 2017

Jan 17, 2018
BUY
$8.35 - $14.4 $267,333 - $461,030
32,016 Added 20.3%
189,697 $1.67 Million
Q3 2017

Nov 13, 2017
BUY
$11.1 - $14.5 $1.75 Million - $2.29 Million
157,681
157,681 $2.11 Million

Others Institutions Holding CHRS

# of Institutions
122
Shares Held
57.9M
Call Options Held
89.3K
Put Options Held
31K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $139M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email